The baseline levels of interleukin-6, CRP and leptin predicted incident MetS in schizophrenia patients, and it has been suggested that patients at increased risk of suffering the cardiometabolic adverse effects of antipsychotics could be identified before treatment initiation36,37. The gene discussed is CRP; the disease is metabolic syndrome.